At the ACNP 62nd Annual Meeting, Mickey Matsumoto, Ph.D., Chief Scientific Officer of Arialys, gave a Hot Topic Presentation entitled, "Monoclonal Humanized One-Armed Antibody Blocking Therapy for Anti-NMDA Receptor Autoantibody-Mediated CNS Disorders."

Click here to view the abstract (P543).

View the presentation here.